Purinergic signalling and immune cells

Purinergic Signal. 2014 Dec;10(4):529-64. doi: 10.1007/s11302-014-9427-2. Epub 2014 Oct 29.


This review article provides a historical perspective on the role of purinergic signalling in the regulation of various subsets of immune cells from early discoveries to current understanding. It is now recognised that adenosine 5'-triphosphate (ATP) and other nucleotides are released from cells following stress or injury. They can act on virtually all subsets of immune cells through a spectrum of P2X ligand-gated ion channels and G protein-coupled P2Y receptors. Furthermore, ATP is rapidly degraded into adenosine by ectonucleotidases such as CD39 and CD73, and adenosine exerts additional regulatory effects through its own receptors. The resulting effect ranges from stimulation to tolerance depending on the amount and time courses of nucleotides released, and the balance between ATP and adenosine. This review identifies the various receptors involved in the different subsets of immune cells and their effects on the function of these cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Immune System / immunology*
  • Immune System / metabolism*
  • Purines / immunology*
  • Receptors, Purinergic / metabolism*
  • Signal Transduction / physiology


  • Purines
  • Receptors, Purinergic